Global Radiolabelled ADME Studies Market Research Report 2025(Status and Outlook)

March 2025 | 141 pages | ID: GC1C26222419EN
Bosson Research

Abstracts

Report Overview

Radiolabelled ADME studies utilize radiolabelled (radioactive) versions of a drug to track its journey through the body. The radioactive label allows for precise detection and quantification of the drug and its metabolites, facilitating a comprehensive understanding of its pharmacokinetic profile.

This report provides a deep insight into the global Radiolabelled ADME Studies market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radiolabelled ADME Studies Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radiolabelled ADME Studies market in any manner.

Global Radiolabelled ADME Studies Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Charles River

Eurofins Scientific

Evotec

Labcorp

Sekisui Medical

XenoTech (BioIVT)

QPS

BioDuro-Sundia

Quotient Sciences

Chelatec

HMR

Nuvisan

Fluorizon

WuXi AppTec

Pharmaron

InnoStar

Medicilon

Frontage

Value Pharmaceutical

New Radiomedicine Technology

Market Segmentation (by Type)

C-14

H-3

Others

Market Segmentation (by Application)

Biopharmaceutical Companies

Government and Academic Institutes

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Radiolabelled ADME Studies Market
• Overview of the regional outlook of the Radiolabelled ADME Studies Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiolabelled ADME Studies Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Radiolabelled ADME Studies
1.2 Key Market Segments
  1.2.1 Radiolabelled ADME Studies Segment by Type
  1.2.2 Radiolabelled ADME Studies Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 RADIOLABELLED ADME STUDIES MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 RADIOLABELLED ADME STUDIES MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Radiolabelled ADME Studies Product Life Cycle
3.3 Global Radiolabelled ADME Studies Revenue Market Share by Company (2020-2025)
3.4 Radiolabelled ADME Studies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Radiolabelled ADME Studies Company Headquarters, Area Served, Product Type
3.6 Radiolabelled ADME Studies Market Competitive Situation and Trends
  3.6.1 Radiolabelled ADME Studies Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Radiolabelled ADME Studies Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 RADIOLABELLED ADME STUDIES VALUE CHAIN ANALYSIS

4.1 Radiolabelled ADME Studies Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF RADIOLABELLED ADME STUDIES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Radiolabelled ADME Studies Market Porter's Five Forces Analysis

6 RADIOLABELLED ADME STUDIES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radiolabelled ADME Studies Market Size Market Share by Type (2020-2025)
6.3 Global Radiolabelled ADME Studies Market Size Growth Rate by Type (2021-2025)

7 RADIOLABELLED ADME STUDIES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radiolabelled ADME Studies Market Size (M USD) by Application (2020-2025)
7.3 Global Radiolabelled ADME Studies Sales Growth Rate by Application (2020-2025)

8 RADIOLABELLED ADME STUDIES MARKET SEGMENTATION BY REGION

8.1 Global Radiolabelled ADME Studies Market Size by Region
  8.1.1 Global Radiolabelled ADME Studies Market Size by Region
  8.1.2 Global Radiolabelled ADME Studies Market Size Market Share by Region
8.2 North America
  8.2.1 North America Radiolabelled ADME Studies Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Radiolabelled ADME Studies Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Spain
8.4 Asia Pacific
  8.4.1 Asia Pacific Radiolabelled ADME Studies Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Radiolabelled ADME Studies Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Radiolabelled ADME Studies Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Charles River
  9.1.1 Charles River Basic Information
  9.1.2 Charles River Radiolabelled ADME Studies Product Overview
  9.1.3 Charles River Radiolabelled ADME Studies Product Market Performance
  9.1.4 Charles River SWOT Analysis
  9.1.5 Charles River Business Overview
  9.1.6 Charles River Recent Developments
9.2 Eurofins Scientific
  9.2.1 Eurofins Scientific Basic Information
  9.2.2 Eurofins Scientific Radiolabelled ADME Studies Product Overview
  9.2.3 Eurofins Scientific Radiolabelled ADME Studies Product Market Performance
  9.2.4 Eurofins Scientific SWOT Analysis
  9.2.5 Eurofins Scientific Business Overview
  9.2.6 Eurofins Scientific Recent Developments
9.3 Evotec
  9.3.1 Evotec Basic Information
  9.3.2 Evotec Radiolabelled ADME Studies Product Overview
  9.3.3 Evotec Radiolabelled ADME Studies Product Market Performance
  9.3.4 Evotec SWOT Analysis
  9.3.5 Evotec Business Overview
  9.3.6 Evotec Recent Developments
9.4 Labcorp
  9.4.1 Labcorp Basic Information
  9.4.2 Labcorp Radiolabelled ADME Studies Product Overview
  9.4.3 Labcorp Radiolabelled ADME Studies Product Market Performance
  9.4.4 Labcorp Business Overview
  9.4.5 Labcorp Recent Developments
9.5 Sekisui Medical
  9.5.1 Sekisui Medical Basic Information
  9.5.2 Sekisui Medical Radiolabelled ADME Studies Product Overview
  9.5.3 Sekisui Medical Radiolabelled ADME Studies Product Market Performance
  9.5.4 Sekisui Medical Business Overview
  9.5.5 Sekisui Medical Recent Developments
9.6 XenoTech (BioIVT)
  9.6.1 XenoTech (BioIVT) Basic Information
  9.6.2 XenoTech (BioIVT) Radiolabelled ADME Studies Product Overview
  9.6.3 XenoTech (BioIVT) Radiolabelled ADME Studies Product Market Performance
  9.6.4 XenoTech (BioIVT) Business Overview
  9.6.5 XenoTech (BioIVT) Recent Developments
9.7 QPS
  9.7.1 QPS Basic Information
  9.7.2 QPS Radiolabelled ADME Studies Product Overview
  9.7.3 QPS Radiolabelled ADME Studies Product Market Performance
  9.7.4 QPS Business Overview
  9.7.5 QPS Recent Developments
9.8 BioDuro-Sundia
  9.8.1 BioDuro-Sundia Basic Information
  9.8.2 BioDuro-Sundia Radiolabelled ADME Studies Product Overview
  9.8.3 BioDuro-Sundia Radiolabelled ADME Studies Product Market Performance
  9.8.4 BioDuro-Sundia Business Overview
  9.8.5 BioDuro-Sundia Recent Developments
9.9 Quotient Sciences
  9.9.1 Quotient Sciences Basic Information
  9.9.2 Quotient Sciences Radiolabelled ADME Studies Product Overview
  9.9.3 Quotient Sciences Radiolabelled ADME Studies Product Market Performance
  9.9.4 Quotient Sciences Business Overview
  9.9.5 Quotient Sciences Recent Developments
9.10 Chelatec
  9.10.1 Chelatec Basic Information
  9.10.2 Chelatec Radiolabelled ADME Studies Product Overview
  9.10.3 Chelatec Radiolabelled ADME Studies Product Market Performance
  9.10.4 Chelatec Business Overview
  9.10.5 Chelatec Recent Developments
9.11 HMR
  9.11.1 HMR Basic Information
  9.11.2 HMR Radiolabelled ADME Studies Product Overview
  9.11.3 HMR Radiolabelled ADME Studies Product Market Performance
  9.11.4 HMR Business Overview
  9.11.5 HMR Recent Developments
9.12 Nuvisan
  9.12.1 Nuvisan Basic Information
  9.12.2 Nuvisan Radiolabelled ADME Studies Product Overview
  9.12.3 Nuvisan Radiolabelled ADME Studies Product Market Performance
  9.12.4 Nuvisan Business Overview
  9.12.5 Nuvisan Recent Developments
9.13 Fluorizon
  9.13.1 Fluorizon Basic Information
  9.13.2 Fluorizon Radiolabelled ADME Studies Product Overview
  9.13.3 Fluorizon Radiolabelled ADME Studies Product Market Performance
  9.13.4 Fluorizon Business Overview
  9.13.5 Fluorizon Recent Developments
9.14 WuXi AppTec
  9.14.1 WuXi AppTec Basic Information
  9.14.2 WuXi AppTec Radiolabelled ADME Studies Product Overview
  9.14.3 WuXi AppTec Radiolabelled ADME Studies Product Market Performance
  9.14.4 WuXi AppTec Business Overview
  9.14.5 WuXi AppTec Recent Developments
9.15 Pharmaron
  9.15.1 Pharmaron Basic Information
  9.15.2 Pharmaron Radiolabelled ADME Studies Product Overview
  9.15.3 Pharmaron Radiolabelled ADME Studies Product Market Performance
  9.15.4 Pharmaron Business Overview
  9.15.5 Pharmaron Recent Developments
9.16 InnoStar
  9.16.1 InnoStar Basic Information
  9.16.2 InnoStar Radiolabelled ADME Studies Product Overview
  9.16.3 InnoStar Radiolabelled ADME Studies Product Market Performance
  9.16.4 InnoStar Business Overview
  9.16.5 InnoStar Recent Developments
9.17 Medicilon
  9.17.1 Medicilon Basic Information
  9.17.2 Medicilon Radiolabelled ADME Studies Product Overview
  9.17.3 Medicilon Radiolabelled ADME Studies Product Market Performance
  9.17.4 Medicilon Business Overview
  9.17.5 Medicilon Recent Developments
9.18 Frontage
  9.18.1 Frontage Basic Information
  9.18.2 Frontage Radiolabelled ADME Studies Product Overview
  9.18.3 Frontage Radiolabelled ADME Studies Product Market Performance
  9.18.4 Frontage Business Overview
  9.18.5 Frontage Recent Developments
9.19 Value Pharmaceutical
  9.19.1 Value Pharmaceutical Basic Information
  9.19.2 Value Pharmaceutical Radiolabelled ADME Studies Product Overview
  9.19.3 Value Pharmaceutical Radiolabelled ADME Studies Product Market Performance
  9.19.4 Value Pharmaceutical Business Overview
  9.19.5 Value Pharmaceutical Recent Developments
9.20 New Radiomedicine Technology
  9.20.1 New Radiomedicine Technology Basic Information
  9.20.2 New Radiomedicine Technology Radiolabelled ADME Studies Product Overview
  9.20.3 New Radiomedicine Technology Radiolabelled ADME Studies Product Market Performance
  9.20.4 New Radiomedicine Technology Business Overview
  9.20.5 New Radiomedicine Technology Recent Developments

10 RADIOLABELLED ADME STUDIES MARKET FORECAST BY REGION

10.1 Global Radiolabelled ADME Studies Market Size Forecast
10.2 Global Radiolabelled ADME Studies Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Radiolabelled ADME Studies Market Size Forecast by Country
  10.2.3 Asia Pacific Radiolabelled ADME Studies Market Size Forecast by Region
  10.2.4 South America Radiolabelled ADME Studies Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Sales of Radiolabelled ADME Studies by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

11.1 Global Radiolabelled ADME Studies Market Forecast by Type (2026-2033)
11.2 Global Radiolabelled ADME Studies Market Forecast by Application (2026-2033)

12 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Radiolabelled ADME Studies Market Size Comparison by Region (M USD)
Table 5. Global Radiolabelled ADME Studies Revenue (M USD) by Company (2020-2025)
Table 6. Global Radiolabelled ADME Studies Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiolabelled ADME Studies as of 2024)
Table 8. Radiolabelled ADME Studies Company Headquarters and Area Served
Table 9. Company Radiolabelled ADME Studies Product Type
Table 10. Global Radiolabelled ADME Studies Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Radiolabelled ADME Studies Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Radiolabelled ADME Studies Market Size by Type (M USD)
Table 21. Global Radiolabelled ADME Studies Market Size (M USD) by Type (2020-2025)
Table 22. Global Radiolabelled ADME Studies Market Size Share by Type (2020-2025)
Table 23. Global Radiolabelled ADME Studies Market Size Growth Rate by Type (2021-2025)
Table 24. Global Radiolabelled ADME Studies Market Size by Application
Table 25. Global Radiolabelled ADME Studies Market Size by Application (2020-2025) & (M USD)
Table 26. Global Radiolabelled ADME Studies Market Share by Application (2020-2025)
Table 27. Global Radiolabelled ADME Studies Sales Growth Rate by Application (2020-2025)
Table 28. Global Radiolabelled ADME Studies Market Size by Region (2020-2025) & (M USD)
Table 29. Global Radiolabelled ADME Studies Market Size Market Share by Region (2020-2025)
Table 30. North America Radiolabelled ADME Studies Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Radiolabelled ADME Studies Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Radiolabelled ADME Studies Market Size by Region (2020-2025) & (M USD)
Table 33. South America Radiolabelled ADME Studies Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Radiolabelled ADME Studies Market Size by Region (2020-2025) & (M USD)
Table 35. Charles River Basic Information
Table 36. Charles River Radiolabelled ADME Studies Product Overview
Table 37. Charles River Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Charles River SWOT Analysis
Table 39. Charles River Business Overview
Table 40. Charles River Recent Developments
Table 41. Eurofins Scientific Basic Information
Table 42. Eurofins Scientific Radiolabelled ADME Studies Product Overview
Table 43. Eurofins Scientific Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Eurofins Scientific SWOT Analysis
Table 45. Eurofins Scientific Business Overview
Table 46. Eurofins Scientific Recent Developments
Table 47. Evotec Basic Information
Table 48. Evotec Radiolabelled ADME Studies Product Overview
Table 49. Evotec Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Evotec SWOT Analysis
Table 51. Evotec Business Overview
Table 52. Evotec Recent Developments
Table 53. Labcorp Basic Information
Table 54. Labcorp Radiolabelled ADME Studies Product Overview
Table 55. Labcorp Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 56. Labcorp Business Overview
Table 57. Labcorp Recent Developments
Table 58. Sekisui Medical Basic Information
Table 59. Sekisui Medical Radiolabelled ADME Studies Product Overview
Table 60. Sekisui Medical Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Sekisui Medical Business Overview
Table 62. Sekisui Medical Recent Developments
Table 63. XenoTech (BioIVT) Basic Information
Table 64. XenoTech (BioIVT) Radiolabelled ADME Studies Product Overview
Table 65. XenoTech (BioIVT) Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 66. XenoTech (BioIVT) Business Overview
Table 67. XenoTech (BioIVT) Recent Developments
Table 68. QPS Basic Information
Table 69. QPS Radiolabelled ADME Studies Product Overview
Table 70. QPS Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 71. QPS Business Overview
Table 72. QPS Recent Developments
Table 73. BioDuro-Sundia Basic Information
Table 74. BioDuro-Sundia Radiolabelled ADME Studies Product Overview
Table 75. BioDuro-Sundia Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 76. BioDuro-Sundia Business Overview
Table 77. BioDuro-Sundia Recent Developments
Table 78. Quotient Sciences Basic Information
Table 79. Quotient Sciences Radiolabelled ADME Studies Product Overview
Table 80. Quotient Sciences Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 81. Quotient Sciences Business Overview
Table 82. Quotient Sciences Recent Developments
Table 83. Chelatec Basic Information
Table 84. Chelatec Radiolabelled ADME Studies Product Overview
Table 85. Chelatec Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Chelatec Business Overview
Table 87. Chelatec Recent Developments
Table 88. HMR Basic Information
Table 89. HMR Radiolabelled ADME Studies Product Overview
Table 90. HMR Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 91. HMR Business Overview
Table 92. HMR Recent Developments
Table 93. Nuvisan Basic Information
Table 94. Nuvisan Radiolabelled ADME Studies Product Overview
Table 95. Nuvisan Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Nuvisan Business Overview
Table 97. Nuvisan Recent Developments
Table 98. Fluorizon Basic Information
Table 99. Fluorizon Radiolabelled ADME Studies Product Overview
Table 100. Fluorizon Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 101. Fluorizon Business Overview
Table 102. Fluorizon Recent Developments
Table 103. WuXi AppTec Basic Information
Table 104. WuXi AppTec Radiolabelled ADME Studies Product Overview
Table 105. WuXi AppTec Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 106. WuXi AppTec Business Overview
Table 107. WuXi AppTec Recent Developments
Table 108. Pharmaron Basic Information
Table 109. Pharmaron Radiolabelled ADME Studies Product Overview
Table 110. Pharmaron Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 111. Pharmaron Business Overview
Table 112. Pharmaron Recent Developments
Table 113. InnoStar Basic Information
Table 114. InnoStar Radiolabelled ADME Studies Product Overview
Table 115. InnoStar Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 116. InnoStar Business Overview
Table 117. InnoStar Recent Developments
Table 118. Medicilon Basic Information
Table 119. Medicilon Radiolabelled ADME Studies Product Overview
Table 120. Medicilon Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 121. Medicilon Business Overview
Table 122. Medicilon Recent Developments
Table 123. Frontage Basic Information
Table 124. Frontage Radiolabelled ADME Studies Product Overview
Table 125. Frontage Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 126. Frontage Business Overview
Table 127. Frontage Recent Developments
Table 128. Value Pharmaceutical Basic Information
Table 129. Value Pharmaceutical Radiolabelled ADME Studies Product Overview
Table 130. Value Pharmaceutical Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 131. Value Pharmaceutical Business Overview
Table 132. Value Pharmaceutical Recent Developments
Table 133. New Radiomedicine Technology Basic Information
Table 134. New Radiomedicine Technology Radiolabelled ADME Studies Product Overview
Table 135. New Radiomedicine Technology Radiolabelled ADME Studies Revenue (M USD) and Gross Margin (2020-2025)
Table 136. New Radiomedicine Technology Business Overview
Table 137. New Radiomedicine Technology Recent Developments
Table 138. Global Radiolabelled ADME Studies Market Size Forecast by Region (2026-2033) & (M USD)
Table 139. North America Radiolabelled ADME Studies Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Europe Radiolabelled ADME Studies Market Size Forecast by Country (2026-2033) & (M USD)
Table 141. Asia Pacific Radiolabelled ADME Studies Market Size Forecast by Region (2026-2033) & (M USD)
Table 142. South America Radiolabelled ADME Studies Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Middle East and Africa Radiolabelled ADME Studies Market Size Forecast by Country (2026-2033) & (M USD)
Table 144. Global Radiolabelled ADME Studies Market Size Forecast by Type (2026-2033) & (M USD)
Table 145. Global Radiolabelled ADME Studies Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Industry Chain of Radiolabelled ADME Studies
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiolabelled ADME Studies Market Size (M USD), 2024-2033
Figure 5. Global Radiolabelled ADME Studies Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Radiolabelled ADME Studies Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Radiolabelled ADME Studies Product Life Cycle
Figure 12. Global Radiolabelled ADME Studies Revenue Share by Company in 2024
Figure 13. Radiolabelled ADME Studies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Radiolabelled ADME Studies Revenue in 2024
Figure 15. Value Chain Map of Radiolabelled ADME Studies
Figure 16. Global Radiolabelled ADME Studies Market PEST Analysis
Figure 17. Global Radiolabelled ADME Studies Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Radiolabelled ADME Studies Market Share by Type
Figure 20. Market Size Share of Radiolabelled ADME Studies by Type (2020-2025)
Figure 21. Market Size Share of Radiolabelled ADME Studies by Type in 2024
Figure 22. Global Radiolabelled ADME Studies Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Radiolabelled ADME Studies Market Share by Application
Figure 25. Global Radiolabelled ADME Studies Market Share by Application (2020-2025)
Figure 26. Global Radiolabelled ADME Studies Market Share by Application in 2024
Figure 27. Global Radiolabelled ADME Studies Sales Growth Rate by Application (2020-2025)
Figure 28. Global Radiolabelled ADME Studies Market Size Market Share by Region (2020-2025)
Figure 29. North America Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Radiolabelled ADME Studies Market Size Market Share by Country in 2024
Figure 31. U.S. Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Radiolabelled ADME Studies Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Radiolabelled ADME Studies Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Radiolabelled ADME Studies Market Share by Country in 2024
Figure 36. Germany Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Radiolabelled ADME Studies Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Radiolabelled ADME Studies Market Size Market Share by Region in 2024
Figure 43. China Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Radiolabelled ADME Studies Market Size and Growth Rate (M USD)
Figure 49. South America Radiolabelled ADME Studies Market Size Market Share by Country in 2024
Figure 50. Brazil Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Radiolabelled ADME Studies Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Radiolabelled ADME Studies Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Radiolabelled ADME Studies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Radiolabelled ADME Studies Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Radiolabelled ADME Studies Market Share Forecast by Type (2026-2033)
Figure 62. Global Radiolabelled ADME Studies Market Share Forecast by Application (2026-2033)